Amneal Pharmaceuticals (AMRX) EPS (Basic) Growth (1y) (2019 - 2026)
Amneal Pharmaceuticals (AMRX) EPS (Basic) Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 65.56% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 5.87% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -389.31% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -11.93% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 105.98% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 2,385.12% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -15.37% |
| 10 | Amneal Pharmaceuticals | 5.68 Bn | 5.67 Bn | 320.11 Mn | 211.86% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 211.86% |
| Dec 31, 2025 | 335.65% |
| Sep 30, 2025 | 52.00% |
| Jun 30, 2025 | 109.00% |
| Mar 31, 2025 | 129.77% |
| Dec 31, 2024 | 88.01% |
| Sep 30, 2024 | -39.52% |
| Jun 30, 2024 | -29.94% |
| Mar 31, 2024 | -482.34% |
| Dec 31, 2023 | -1,851.06% |
| Sep 30, 2023 | 453.46% |
| Jun 30, 2023 | 109.69% |
| Mar 31, 2023 | -217.34% |
| Dec 31, 2022 | 32.96% |
| Sep 30, 2022 | 37.42% |
| Jun 30, 2022 | -920.33% |
| Mar 31, 2022 | -131.75% |
| Dec 31, 2021 | -107.89% |
| Sep 30, 2021 | 53.34% |
| Jun 30, 2021 | 219.84% |